Research
Researchers found that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early-stage prostate cancer treatment.
Latest stories
Research
February 7, 2024
Biotherapeutics
January 30, 2024
Cancer
January 26, 2024
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community